N Verses Capital, LLC Sarepta Therapeutics, Inc. Transaction History
N Verses Capital, LLC
- $167 Billion
- Q2 2024
A detailed history of N Verses Capital, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 2,200 shares of SRPT stock, worth $283,624. This represents 0.21% of its overall portfolio holdings.
Number of Shares
2,200
Previous 500
340.0%
Holding current value
$283,624
Previous $64.7 Million
437.0%
% of portfolio
0.21%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
560Shares Held
85.5MCall Options Held
3.67MPut Options Held
1.75M-
Black Rock Inc. New York, NY10.3MShares$1.33 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.04MShares$1.16 Billion0.03% of portfolio
-
Capital International Investors Los Angeles, CA4.32MShares$557 Million0.14% of portfolio
-
State Street Corp Boston, MA4.14MShares$534 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.82MShares$492 Million0.33% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $11.3B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...